Kuala Lumpur, 5 May 2020: Nexgram Industries Sdn Bhd has been appointed as the authorised distributor of antibody IgM/IgG Covid-19 diagnostic kit in Malaysia and Indonesia by Shanghai Liangrun Biomedicine Technology Co Ltd since April 3 2020.
Nexgram Industries is a wholly-owned subsidiary of Nexgram Holdings Bhd (NEXGRAM). Nexgram Industries had also submitted an application to the Ministry of Health for the certification of the diagnostic kit and is currently pending approval.
“Further, Nexgram Industries had also on May 5 appointed Tri-G Technologies Sdn Bhd as the sub-distributor for the distribution of the diagnostic kit,” NEXGRAM said.
Shanghai Liangrun is a company principally engaged in biomedicine technology, while Tri-G is the licensed medical device distributor in Malaysia in collaboration with a network of more than 5,000 medical providers nationwide.
What is our MDA doing? Can see so many listed co said they are waiting for approval from MDA, but none have gotten the approval. Halo, want to wait till more casualties only start to work on the approval kah!!!!! M boleh
Sorry to say...Indonesia is a time bomb for C19 cases due to its intense population. And mind you, Nexgram has pinned its strategy there ahead of others
The Board of Directors of Nexgram is pleased to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 12 March 2020 entered into a Sales Agreement (“Agreement”) with Shanghai Liangrun Biomedicine Technology Co., Ltd (“Shanghai Liangrun”) to sell their product, Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19 (“Diagnostic Kit”) in Malaysia and Indonesia. Besides, Shanghai Liangrun has appointed NISB as the authorised dealer to seek the approvals from the Ministry of Health in Malaysia and relevant authorities in Indonesia for the distribution of the Diagnostic Kit.
Shanghai Liangrun has **directly** appointed NISB as the authorised distributor to seek the approvals from the Ministry of Health in Malaysia and Pharmaceuticals and Medical Devices, Ministry of Health of Republic Indonesia for the distribution of the Diagnostic Kit.
Selling Covid-19 related products might be the last movement the company can do to protect the company. If the products are well accepted/brought, then the company may recovered themselves from doom.
And share price might start to move on end of July or start of August.
Investors are waiting for the result also the RCPS result.
Nexgram not active in the news. Marketing is not just about the products (nexgram sells same covid test kit as HWGB yet the latter share price already up and up. Company's image, projecting potential or even 'empty can noise' is also vital. Haji Mazru needs to more on company's image promotion.
HONG KONG - A Chinese-made coronavirus vaccine could be ready for market as early as the end of this year, China's State-owned Assets Supervision and Administration Commission (SASAC) said in a social media post.
In trials, more than 2,000 people have received vaccines developed by the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products. A vaccine could be ready for the market as early as the end of this year or early 2021, according to the May 29 post on Chinese social media platform WeChat.
Vaccines from the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products had entered Phase II clinical trials. Both groups are affiliated with state-owned pharmaceutical group Sinopharm, whose management is overseen by SASAC.
The Beijing Institute of Biological Products' production line will have an annual manufacturing capacity of 100 million to 120 million doses, according to the article.
China has five coronavirus vaccines in human trials. Neither company could be reached for comment on Saturday evening.
Only vaccine will be the game changer of Nexgem's fate. Test kid at myr500 seems too expensive, not so relevant to health dept. That say it's vaccine at myr500, how many can afford this injection during bad times?
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
fzank
1,537 posts
Posted by fzank > 2020-05-14 09:51 | Report Abuse
now ... the others related covid stocks coming down ... nexgram also follows ???? i really don't understand ????